VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ESH CML 2022 | Examples of challenging scenarios for TFR in CML & how to manage them

Susanne Saussele, MD, University of Heidelberg, Mannheim, Germany, shares some examples of challenging scenarios for treatment-free remission (TFR) in chronic myeloid leukemia (CML), including patients with undetectable BCR-ABL levels at therapy initiation whose BCR-ABL levels rise fast after treatment discontinuation, and patients who experience severe adverse events with TKIs. This interview took place at the 24th Annual John Goldman Conference on Chronic Myeloid Leukemia (ESH CML) held in Mandelieu-La Napoule, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.


BMS, Incyte, Novartis, Honoraria: BMS, Incyte, Novartis, Pfizer, Roche

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter